The global catenin beta market is anticipated to grow at a significant CAGR during the forecast period. Catenin beta is also known as beta-catenin 1. It is a protein that is encoded by the CTNNB1 gene in humans and is a dual function protein that is involved in the regulation and coordination of cell, cell adhesion and gene transcription. The major factor driving the growth of the market is the rising prevalence of genetic disorders across the globe.
According to the Genetic and Rare Diseases Information Center (GARD), an estimated 25-30 million people are living with a genetic disorder in the US. Furthermore, catenin beta also supports to promote the progression of tumors by suppressing the responses from T-cell. Its activity is controlled by a large number of binding partners affecting its stability, cellular localization and transcriptional activity. Moreover, it enables carcinogenesis and contributes to tumor progression of several cancers such as colon cancer, hepatocellular carcinoma, pancreatic cancer, lung cancer and ovarian cancer.
Hence, the rising prevalence of cancer is a major factor leveraging the market growth. According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Some major players in the market include GlaxoSmithKline plc, Merck KGaA, and Novartis International AG, among others.
To Request a Sample of our Report on Catenin Beta Market: https://www.omrglobal.com/request-sample/catenin-beta-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- GlaxoSmithKline plc, Merck KGaA, and Novartis International AG, among others.
A full Report of Catenin Beta Market is Available @ https://www.omrglobal.com/industry-reports/catenin-beta-market
Catenin Beta Market Report by Segment
By Type
- BBI-801
- Exisulind
- M-101
- Nefopam Hydrochloride
- Others
By Application
- Dermatology
- Oncology
- Genetic Disorder
- Others
Catenin Beta Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
